Dr. M. Los

Naam Dr. M. Los 
Specialisme Interne Geneeskunde
Subspecialisme Hematologie, oncologie
Opleiding

Opleiding tot arts
Universiteit Utrecht

Opleiding tot medisch specialist
Universitair Medisch Centrum Utrecht

Specialist sinds 2003
Talen Nederlands, Duits, Engels
Publicaties

1. Los M, Jansen GH, Kaelin WG, Lips CJM, Blijham GH, Voest EE. Expression pattern of the von Hippel-Lindau protein in human tissues. Lab Invest 1996; 75:231-238

2. Los M, Aarsman CJ, Terpstra L, Wittebol-Post D, Lips CJM, Blijham GH, Voest EE. Elevated ocular levels of vascular endothelial growth factor in patiens with von Hippel-Lindau disease. Ann Oncol 1997; 8:1015-1022

3. Los M, Zeamari S, Foekens JA, Gebbink MFBG, Voest EE. Regulation of the urokinase-type plasminogen activator system by the von Hippel-Lindau tumor suppressor gene. Cancer Res 1999; 59:4440-4450

4. Los M, Kerckhaert OA, Zewald R, van Amstel HK, Voest EE. Mutational analysis of endothelial cells derived from von Hippel-Lindau related renal cancer. J Natl Cancer Inst 2000; 92:1688-1689

5. Los M, Voest EE. The potential role of antivascular therapy in adjuvant and neoadjuvant treatment of cancer. Semin Oncol 2001; 28:93-105

6. Los M, Voest EE. Genetic control of angiogenesis by tumor suppressor genes. In Tumor Angiogenesis and Microcirculation. Marcel Dekker, inc. New York 2001

7. Los M, Links TP, Lenders JW, Voest EE. Von Hippel-Lindau disease. Ned Tijdschr Geneesk 2000; 144:947-501

8. Hes FJ, Los M, van der Luijt RB. Van gen naar ziekte; de ziekte van von Hippel-Lindau gene. Ned Tijdschr Geneesk 2002; 146:1364-7

9. Bluyssen  HAR, Lolkema MP, van Beest M, Boone M, Snijckers CM, Los M, Gebbink MF, Braam B, Holstege FC, Giles RH, Voest EE. Fibronectin is a hypoxia-independent target of the tumor suppressor VHL. FEBS Lett. 2004; 556: 137-42

10. Los M, Voest EE, Borel Rinkes IHM. VEGF as a target of therapy in gastrointestinal oncology. Dig Surg. 2005;22(4):282-93.

11. Los M, Roodhart JM, Voest EE. Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer. Oncologist. 2007 Apr;12(4):443-50.

12. Sonke GS, Beerepoot LV, Los M. A patient with subdiaphragmatic air. Neth J Med, 2008 Feb; 66(2): 89-90